• AMSTERDAM
  • BRUSSELS
  • DÜSSELDORF
  • MADRID
  • MANNHEIM
  • MUNICH
  • PARIS

Press

HOYNG ROKH MONEGIER and VÉRON & ASSOCIÉS to join forces

20 March 2018
Tue, 03/20/2018 (All day)

HOYNG ROKH MONEGIER and top-tier French patent litigation firm VÉRON & ASSOCIÉS are joining forces.
On 3 April 2018, VÉRON & ASSOCIÉS's team will move to HOYNG ROKH MONEGIER AARPI's offices in Paris (located at 40 Rue La Boétie), while remaining structurally independent.

In the summer, VÉRON & ASSOCIÉS will officially join HOYNG ROKH MONEGIER AARPI, which will become HOYNG ROKH MONEGIER VERON AARPI in France. With offices in Paris and Lyon, the French team will have 25 specialists in IP and pharmaceutical law, including 8 partners.

  • On 27 November 2018 the Court of Appeal of The Hague in the Netherlands reversed the first instance court’s decision, confirming the validity of AstraZeneca’s patents on their breast cancer drug Faslodex® and reinstating the earlier injunction against Sandoz in PI proceedings.
  • In the landmark Philips Nokia judgement of 1 December 2011 (joined cases C 446/09 and C 495/09) the CJEU responded to a referral by the Antwerp Court of First Instance that in the context of an infringement action it is up to the holder of the intellectual property right to demonstrate that the allegedly infringing goods are intended to be put on sale in the European Union.
  • The EUIPO has released its long awaited “Study on legislative measures related to online IPR infringements”, Carina Gommers and Stephanie Hermoye drafted the Belgian submission on civil measures.
  • Juan José Marín, Full Professor of Civil Law and founder of the Law Offices of Juan José Marín, brings his intellectual property expertise to HOYNG ROKH MONEGIER, where he will lead the copyright practice group.
  • Fabienne Brison is pleased to announce the publication of the 4th edition of "Huldeboek/Hommage à Jan Corbet: Het Belgische auteursrecht. Artikelsgewijze commentaar / Le droit d'auteur belge. Commentaire par article", published by Larcier.